Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Zhibitai Capsules for the Treatment of Primary Hyperlipidemia (Tan yu hu Jie, qi Xue bu li Zheng) A Randomized, Double-blind, Parallel Controlled, Multicenter, Phase II Clinical Trial

NCT06822946 is registered in ClinicalTrials.gov with Chengdu Diao Jiuhong Pharmaceutical Factory as lead sponsor.

NCT NCT06822946
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06822946 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Zhibitai Capsules for the Treatment of Primary Hyperlipidemia (Tan yu hu Jie, qi Xue bu li Zheng) A Randomized, Double-blind, Parallel Controlled, Multicenter, Phase II Clinical Trial
Lead sponsor
Chengdu Diao Jiuhong Pharmaceutical Factory
Phase
Phase 2
Overall status
Completed
Start date
March 27, 2025
Completion date
February 27, 2026
Enrollment
201 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

primary hyperlipidemia